CAMUS is a randomized, double-blind, two arm trial with 369 participants with Benign Prostatic Hyperplasia (BPH), approximately equally allocated to either the Serenoa repens (saw palmetto) extract or placebo over a 72 week period in escalating doses over three consecutive 24 weeks periods, beginning with 320 mg, then 640 mg, and then 960 mg daily . Participants continue on study treatment until they meet a protocol defined reason for treatment discontinuation or complete the 72 week treatment period. The 11 CAMUS clinical centers initiated recruitment June 5, 2008 and successfully completed randomization of 369 subjects on April 17, 2009. This is an application for continued funding for the Data Coordinating Center (DCC) for CAMUS to ensure that follow up of all participants, data collection entry and management and preparation and publication of results is completed.
Specific Aims for this continuation application are to: 1. Complete CAMUS the protocol-specified treatment, follow-up and close out activities 2. Prepare the final dataset, and 3. Complete planned publications, including final results and other papers based on the final trial dataset The DCC's role in this during the period of this continued application includes, data entry for the additional 8000 page equivalents of data expected in this funding period;data editing, query generation and creation of a final analysis data set with a data dictionary and missing data report;coordination and conduct of Executive Committee, Steering Committee, sub-committee and study coordinator meetings;preparation of DSMB and IND reports and the analysis of data and preparation of abstracts, manuscripts and presentations for CAMUS.

Public Health Relevance

Serenoa Repens (sawpalmetto) is a widely used over the counter agent in the treatment of BPH. So far there is no evidence of its effectiveness in the treatment of BPH. If it is indeed effective at reducing lower urinary tract symptoms, it may well be preferred by many men based on the """"""""natural therapy"""""""" appeal, its favorable side-effect profile, and its cost, relative to the prescription medications for BPH.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project--Cooperative Agreements (U01)
Project #
2U01DK063788-08
Application #
7992636
Study Section
Special Emphasis Panel (ZDK1-GRB-R (M2))
Program Officer
Kusek, John W
Project Start
2002-09-30
Project End
2012-06-30
Budget Start
2010-09-20
Budget End
2011-06-30
Support Year
8
Fiscal Year
2010
Total Cost
$514,913
Indirect Cost
Name
University of Alabama Birmingham
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Lee, Jeannette Y; Moore, Page; Kusek, John et al. (2014) Treatment assignment guesses by study participants in a double-blind dose escalation clinical trial of saw palmetto. J Altern Complement Med 20:48-52
Barry, Michael J; Cantor, Alan; Roehrborn, Claus G et al. (2013) Relationships among participant international prostate symptom score, benign prostatic hyperplasia impact index changes and global ratings of change in a trial of phytotherapy in men with lower urinary tract symptoms. J Urol 189:987-92
Andriole, Gerald L; McCullum-Hill, Christie; Sandhu, Gurdarshan S et al. (2013) The effect of increasing doses of saw palmetto fruit extract on serum prostate specific antigen: analysis of the CAMUS randomized trial. J Urol 189:486-92
Helfand, Brian T; Lee, Jeanette Y; Sharp, Victoria et al. (2012) Associations between improvements in lower urinary tract symptoms and sleep disturbance over time in the CAMUS trial. J Urol 188:2288-93
Barry, Michael J; Avins, Andrew L; Meleth, Sreelatha et al. (2011) Performance of the American Urological Association Symptom Index with and without an additional urge incontinence item. Urology 78:550-4
Barry, Michael J; Meleth, Sreelatha; Lee, Jeannette Y et al. (2011) Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial. JAMA 306:1344-51
Helfand, Brian T; McVary, Kevin T; Meleth, Sreelatha et al. (2011) The relationship between lower urinary tract symptom severity and sleep disturbance in the CAMUS trial. J Urol 185:2223-8
Lee, Jeannette Y; Foster Jr, Harris E; McVary, Kevin T et al. (2011) Recruitment of participants to a clinical trial of botanical therapy for benign prostatic hyperplasia. J Altern Complement Med 17:469-72
Lee, Jeannette; Andriole, Gerald; Avins, Andrew et al. (2009) Redesigning a large-scale clinical trial in response to negative external trial results: the CAMUS study of phytotherapy for benign prostatic hyperplasia. Clin Trials 6:628-36